UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 375

Sortiert nach

New drugs in acute myeloid leukemia

Annals of oncology, 2016-05, Vol.27 (5), p.770-778

2016

Link zum Volltext

Verfügbarkeit prüfen

IDH1 and IDH2 mutations in myelodysplastic syndromes and role in disease progression

Leukemia, 2016-04, Vol.30 (4), p.980-984

2016

Link zum Volltext

Verfügbarkeit prüfen

Resistance prediction in AML: analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOG and MD Anderson Cancer Center

Leukemia, 2015-02, Vol.29 (2), p.312-320

2015

Link zum Volltext

Verfügbarkeit prüfen

Declining rates of treatment-related mortality in patients with newly diagnosed AML given 'intense' induction regimens: a report from SWOG and MD Anderson

Leukemia, 2014-02, Vol.28 (2), p.289-292

2014

Link zum Volltext

Verfügbarkeit prüfen

Role of cytokines in the treatment of acute leukemias: a review

Leukemia, 2006-04, Vol.20 (4), p.563-571

RAVANDI, F

2006

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of decitabine and gemtuzumab ozogamicin in newly diagnosed and relapsed acute myeloid leukemia and high-risk myelodysplastic syndrome

Leukemia, 2016-02, Vol.30 (2), p.268-273

2016

Link zum Volltext

Verfügbarkeit prüfen

Therapy-related acute promyelocytic leukemia

Haematologica (Roma), 2011-04, Vol.96 (4), p.493-495

Ravandi, Farhad

2011

Link zum Volltext

Verfügbarkeit prüfen

Selective, novel spleen tyrosine kinase (Syk) inhibitors suppress chronic lymphocytic leukemia B-cell activation and migration

Leukemia, 2012-07, Vol.26 (7), p.1576-1583

2012

Link zum Volltext

Verfügbarkeit prüfen

A prognostic score for patients with lower risk myelodysplastic syndrome

Leukemia, 2008-03, Vol.22 (3), p.538-543

2008

Link zum Volltext

Verfügbarkeit prüfen

Achievement of a negative minimal residual disease state after hypomethylating agent therapy in older patients with AML reduces the risk of relapse

Leukemia, 2018-01, Vol.32 (1), p.241-244

2018

Link zum Volltext

Verfügbarkeit prüfen

Prognostic significance of 11q23 aberrations in adult acute myeloid leukemia and the role of allogeneic stem cell transplantation

Leukemia, 2013-04, Vol.27 (4), p.836-842

2013

Link zum Volltext

Verfügbarkeit prüfen

P541: OUTCOMES AND MANAGEMENT OF PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA PRESENTING WITH HYPERLEUKOCYTOSIS

HemaSphere, 2022-06, Vol.6, p.440-441

2022

Link zum Volltext

Verfügbarkeit prüfen

Final report of phase II study of sorafenib, cytarabine and idarubicin for initial therapy in younger patients with acute myeloid leukemia

Leukemia, 2014-07, Vol.28 (7), p.1543-1545

2014

Link zum Volltext

Verfügbarkeit prüfen

A CpG island methylator phenotype in acute myeloid leukemia independent of IDH mutations and associated with a favorable outcome

Leukemia, 2017-10, Vol.31 (10), p.2011-2019

2017

Link zum Volltext

Verfügbarkeit prüfen

Characteristics, outcomes, prognostic factors and treatment of patients with T-cell prolymphocytic leukemia (T-PLL)

Annals of oncology, 2017-07, Vol.28 (7), p.1554-1559

2017

Link zum Volltext

Verfügbarkeit prüfen

Influence of IDH on FLT3-ITD status in newly diagnosed AML

Leukemia, 2017-11, Vol.31 (11), p.2526-2529

2017

Link zum Volltext

Verfügbarkeit prüfen

Eradication of Leukemia Stem Cells as a New Goal of Therapy in Leukemia

Clinical cancer research, 2006-01, Vol.12 (2), p.340-344

2006

Link zum Volltext

Verfügbarkeit prüfen

Pruritic arthropod bite‐like papules in T‐cell large granular lymphocytic leukaemia and chronic myelomonocytic leukaemia

Clinical and experimental dermatology, 2018-06, Vol.43 (4), p.449-453

2018

Link zum Volltext

Verfügbarkeit prüfen

The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma: MD Anderson Cancer Center experience

Leukemia, 2014-04, Vol.28 (4), p.973-975

2014

Link zum Volltext

Verfügbarkeit prüfen

A randomized study of decitabine versus conventional care for maintenance therapy in patients with acute myeloid leukemia in complete remission

Leukemia, 2012-11, Vol.26 (11), p.2428-2431

2012

Link zum Volltext

Verfügbarkeit prüfen

A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials

Leukemia, 2017-02, Vol.31 (2), p.318-324

2017

Link zum Volltext

Verfügbarkeit prüfen

The JAK-STAT pathway: a therapeutic target in hematological malignancies

Current cancer drug targets, 2006-12, Vol.6 (8), p.671

2006

Link zum Volltext

Verfügbarkeit prüfen

Adult acute erythroleukemia: an analysis of 91 patients treated at a single institution

Leukemia, 2009-12, Vol.23 (12), p.2275-2280

2009

Link zum Volltext

Verfügbarkeit prüfen

Dynamic acquisition of FLT3 or RAS alterations drive a subset of patients with lower risk MDS to secondary AML

Leukemia, 2013-10, Vol.27 (10), p.2081-2083

2013

Link zum Volltext

Verfügbarkeit prüfen

P695: PROGNOSTIC IMPACT OF ASXL1 MUTATIONS IN CHRONIC PHASE CML

HemaSphere, 2022-06, Vol.6, p.590-591

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 375

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(359)
Mit Volltextzugriff
(363)

Publikationsform

Artikel
(371)
Berichte
(4)

Sprache

Englisch
(375)
Japanisch
(34)

Erscheinungsjahr

n.n

Thema

Science & Technology
(172)
Life Sciences & Biomedicine
(148)
Humans
(137)
Hematology
(96)
Oncology
(84)
Middle Aged
(77)
Adult
(75)
Aged
(72)
Male
(64)
Female
(60)
Biological And Medical Sciences
(56)
Medical Sciences
(54)
Hematologic And Hematopoietic Diseases
(45)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(41)
Treatment Outcome
(41)
Aged, 80 And Over
(39)
Prognosis
(34)
Leukemia
(31)
Adolescent
(27)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(27)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(74)
Blood
(43)
Hemasphere
(37)
Leukemia
(32)
Haematologica
(17)
Leukemia Research
(16)
Clinical Lymphoma, Myeloma And Leukemia
(14)
Cancer
(11)
The Astrophysical Journal
(9)
Biology Of Blood And Marrow Transplantation
(7)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

New drugs in acute myeloid leukemia

IDH1 and IDH2 mutations in myelodysplastic syndromes and role in disease progression

Resistance prediction in AML: analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOG and MD Anderson Cancer Center

Declining rates of treatment-related mortality in patients with newly diagnosed AML given 'intense' induction regimens: a report from SWOG and MD Anderson

Role of cytokines in the treatment of acute leukemias: a review

A phase II study of decitabine and gemtuzumab ozogamicin in newly diagnosed and relapsed acute myeloid leukemia and high-risk myelodysplastic syndrome

Therapy-related acute promyelocytic leukemia

Selective, novel spleen tyrosine kinase (Syk) inhibitors suppress chronic lymphocytic leukemia B-cell activation and migration

A prognostic score for patients with lower risk myelodysplastic syndrome

Achievement of a negative minimal residual disease state after hypomethylating agent therapy in older patients with AML reduces the risk of relapse

Prognostic significance of 11q23 aberrations in adult acute myeloid leukemia and the role of allogeneic stem cell transplantation

P541: OUTCOMES AND MANAGEMENT OF PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA PRESENTING WITH HYPERLEUKOCYTOSIS

Final report of phase II study of sorafenib, cytarabine and idarubicin for initial therapy in younger patients with acute myeloid leukemia

A CpG island methylator phenotype in acute myeloid leukemia independent of IDH mutations and associated with a favorable outcome

Characteristics, outcomes, prognostic factors and treatment of patients with T-cell prolymphocytic leukemia (T-PLL)

Influence of IDH on FLT3-ITD status in newly diagnosed AML

Eradication of Leukemia Stem Cells as a New Goal of Therapy in Leukemia

Pruritic arthropod bite‐like papules in T‐cell large granular lymphocytic leukaemia and chronic myelomonocytic leukaemia

The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma: MD Anderson Cancer Center experience

A randomized study of decitabine versus conventional care for maintenance therapy in patients with acute myeloid leukemia in complete remission

A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials

The JAK-STAT pathway: a therapeutic target in hematological malignancies

Adult acute erythroleukemia: an analysis of 91 patients treated at a single institution

Dynamic acquisition of FLT3 or RAS alterations drive a subset of patients with lower risk MDS to secondary AML

P695: PROGNOSTIC IMPACT OF ASXL1 MUTATIONS IN CHRONIC PHASE CML

Suchergebnisse filtern